How Alibaba overcame Beijing’s crackdown to become an AI giant

How Alibaba overcame Beijing’s crackdown to become an AI giant

On a coldĀ November eveningĀ in Shanghai inĀ 2020, the world’s largest IPO was abruptly canceled by Chinese regulators. It was Ant Group, the fintech affiliate of tech giant Alibaba. The company’s founder Jack Ma, one of China’s most famous billionaires, was under scrutiny for comments seemingly criticising the country’s financial regulators.Ā Ā  What followed was four years of…

Read More
Stocks making the biggest moves premarket: NVO, TSLA, GOOGL, OSCR

Stocks making the biggest moves premarket: NVO, TSLA, GOOGL, OSCR

Check out the companies making the biggest moves in premarket trading: Novo Nordisk — Shares tumbled 10% after the Danish pharmaceutical company’s trial for Alzheimer’s disease failed to meet its main goal of slowing the disease’s progression. Tesla — CEO Elon Musk said on X that the company is close to finalizing its latest artificial-intelligence…

Read More
DOGE ‘doesn’t exist’ with eight months left on its charter

DOGE ‘doesn’t exist’ with eight months left on its charter

U.S. President Donald Trump’s Department of Government Efficiency has disbanded with eight months left to its mandate, ending an initiative launched with fanfare as a symbol of Trump’s pledge to slash the government’s size but which critics say delivered few measurable savings. “That doesn’t exist,” Office of Personnel Management Director Scott Kupor told Reuters earlier…

Read More
Novo Nordisk shares plunge after Alzheimer’s drug trial fails to hit key target

Novo Nordisk shares plunge after Alzheimer’s drug trial fails to hit key target

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg | Getty Images Shares of Novo Nordisk on Monday fell as much 11% after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer’s disease failed to meet its main goal. The trial tested whether semaglutideĀ — the…

Read More